These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11119912

  • 21. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
    Martínez Castelao A, Ramos R, Serón D, Gil-Vernet S, Fiol C, Gómez-Gerique N, Yzaguirre MT, Hurtado I, Sabaté I, Alsina J, Grinyó JM.
    Nefrologia; 2002; 22(4):364-9. PubMed ID: 12369128
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine.
    Satterthwaite R, Aswad S, Sunga V, Shidban H, Bogaard T, Asai P, Khetan U, Akra I, Mendez RG, Mendez R.
    Transplantation; 1998 Feb 15; 65(3):446-9. PubMed ID: 9484771
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S, Demers P, St-Louis G, Boily JG, Tousignant J, Lemieux F, Smeesters C, Corman J, Daloze P.
    Transplant Proc; 1998 Jun 15; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM, Cheung CY, Chan YH, Chak WL, Choi KS, Chau KF, Li CS.
    Transplant Proc; 2000 Nov 15; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of lipoprotein A in renal transplant recipients.
    Innocenti M, Lorenzetti M, Naldi F, Paleologo G, Pasquariello A, Marchetti P, Giannarelli R, Rindi P, Navalesi R, Rizzo G.
    Transplant Proc; 1998 Aug 15; 30(5):2048. PubMed ID: 9723386
    [No Abstract] [Full Text] [Related]

  • 38. Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression.
    Tanabe K, Tokumoto T, Ishikawa N, Shimizu T, Okuda H, Ito S, Shimmura H, Inui M, Harano M, Manu M, Koga S, Ohtsubo S, Suzuki K, Shiroyanagi Y, Goya N, Nakazawa H, Yagisawa T, Nakajima I, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov 15; 32(7):1696-9. PubMed ID: 11119897
    [No Abstract] [Full Text] [Related]

  • 39. Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
    Claesson K, Mayer AD, Squifflet JP, Grabensee B, Eigler FW, Behrend M, Vanrenterghem Y, van Hooff J, Morales JM, Johnson RW, Buchholz B, Land W, Forsythe JL, Neumayer HH, Ericzon BG, Mühlbacher F.
    Transplant Proc; 1998 Jun 15; 30(4):1292-4. PubMed ID: 9636524
    [No Abstract] [Full Text] [Related]

  • 40. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
    Shiroki R, Hoshinaga K, Tsukiashi Y, Higuchi T, Izumitani M, Horiba M, Naide Y.
    Transplant Proc; 1997 Dec 15; 29(8):3571-3. PubMed ID: 9414841
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.